Microfluidic Application in the Neuro field
An innovative project with Hospital de Valdecilla(IDIVAL), together with microLIQUID and CSIC reaches the centre of the technology talent, the MIT in Boston.
A project lead by the Head of Clinical Neurophysiology and the attending physician of Intensive Care Medicine of HUMV and IDIVAL, has been one of the 15 international teams selected by MIT #Idea2Global program, developed by the prestigious Massachusetts Institute of Technology (MIT) in Boston (USA). The project has been developed in close collaboration with Instituto Cajal and Microliquid.
The selected teams have won 6 months of training and mentoring of their innovation projects with professors at MIT and other world-class institutions. The program will provide intensive training in innovation methods, development of collaborative projects and specific mentoring team. Moreover, it will provide the experience to help the projects to change from being a new idea to work in the real life.
WHICH IS THE PROJECT?
The idea of the project of great level of technology comes out from Valdecilla, and through the “Foundation for Innovation and Foresight in Health in Spain” (Fipse), which is a non-profit private entity on health research with the Ministry of health and pharmaceutical companies coverage, has gone to the Technology institute in Massachusetts (MIT) in Boston.
The aim of it is to prevent the supervening brain damage while a patient is in coma. And the way to achieve it is the creation of an innovative electrode capable of detecting phenomena which cause the death of neurons that exacerbate the initial injury.
More information at EL DIARIO MONTAÑES